← Current compounder rows

Current NDC auxiliary source row compounder:3134

This page is keyed by dataset, FDA.report source record ID, and physical source row number. Empty values are shown rather than omitted.

Complete normalized row#

Record Source
ndc_compounder_zip
Product Ndc Raw
72196-0431
Product Ndc
72196-0431
Product Ndc Digits
721960431
Product Type Name
HUMAN COMPOUNDED DRUG
Proprietary Name
Trophamine 3.5%/Dextrose 10% and Heparin 125 units 250ml bag
Proprietary Name Suffix
[empty]
Nonproprietary Name
Trophamine 3.5%/Dextrose 10% and Heparin 125 units 250ml bag
Dosage Form Name
SOLUTION
Route Name
INTRAVENOUS
Marketing Category Name
OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)
Labeler Name
Central Admixture Pharmacy Services, Inc.
Establishment Name
Central Admixture Pharmacy Services, Inc.
Establishment Fei
[empty]
Substance Name
HEPARIN SODIUM; LYSINE ACETATE; SERINE; TYROSINE; N-ACETYLTYROSINE; THREONINE; CYSTEINE HYDROCHLORIDE; HISTIDINE; ARGININE; TAURINE; DEXTROSE MONOHYDRATE; LEUCINE; METHIONINE; GLUTAMIC ACID; PROLINE; ASPARTIC ACID; ISOLEUCINE; ALANINE; GLYCINE; PHENYLALANINE; TRYPTOPHAN; VALINE
Active Ingredients Info
125 U/250 mL; 1.05 g/250 mL; .3325 g/250 mL; .0385 g/250 mL; .21 g/250 mL; .3675 g/250 mL; .021 g/250 mL; .42 g/250 mL; 1.05 g/250 mL; .021875 g/250 mL; 25 g/250 mL; 1.225 g/250 mL; .2975 g/250 mL; .4375 g/250 mL; .595 g/250 mL; .28 g/250 mL; .7175 g/250 mL; .4725 g/250 mL; .315 g/250 mL; .42 g/250 mL; .175 g/250 mL; .6825 g/250 mL
History Active Ingredients Raw
HEPARIN SODIUM; LYSINE ACETATE; SERINE; TYROSINE; N-ACETYLTYROSINE; THREONINE; CYSTEINE HYDROCHLORIDE; HISTIDINE; ARGININE; TAURINE; DEXTROSE MONOHYDRATE; LEUCINE; METHIONINE; GLUTAMIC ACID; PROLINE; ASPARTIC ACID; ISOLEUCINE; ALANINE; GLYCINE; PHENYLALANINE; TRYPTOPHAN; VALINE
History Active Ingredients Info Raw
125 U/250 mL; 1.05 g/250 mL; .3325 g/250 mL; .0385 g/250 mL; .21 g/250 mL; .3675 g/250 mL; .021 g/250 mL; .42 g/250 mL; 1.05 g/250 mL; .021875 g/250 mL; 25 g/250 mL; 1.225 g/250 mL; .2975 g/250 mL; .4375 g/250 mL; .595 g/250 mL; .28 g/250 mL; .7175 g/250 mL; .4725 g/250 mL; .315 g/250 mL; .42 g/250 mL; .175 g/250 mL; .6825 g/250 mL
History Dosage Raw
SOLUTION
Dea Schedule
[empty]
Package Ndc Raw
72196-0431-1
Package Ndc
72196-0431-1
Package Ndc Digits
7219604311
Package Ndc11
72196043101
Package Description
250 mL in 1 BAG (72196-0431-1)
Reporting Period Raw
2025-1
Reporting Period
2025-1
Normalization Status
valid
Source Url
https://www.accessdata.fda.gov/cder/compounders_ndc_directory.zip
Source Archive
compounders_ndc_directory.zip
Source File
compounders_ndc_directory.txt
Source Date
2026-09-18
Source Last Modified
Fri, 18 Sep 2026 15:17:23 GMT
Source Archive Sha256
222f6800f79cb1a0fa79431b7226bd6b34899999dbf086af51004a96774ada98
Source Member Sha256
f8d9743e5616579a34d614887e86a53913efa0a63d3138d59d2f87cbb4d0cc17
Source Record Id
compounder:3134
Source Row Number
3134
Source Row Hash
792d1fafdfa2c05838babae064f75a7cf747977dc1d4103e7336491c867c6f4c
Import Run Id
20261119T172627Z
Loaded At
2026-11-19 17:42:45

Exact raw FDA source fields#

{
    "ROUTENAME": "INTRAVENOUS",
    "PRODUCTNDC": "72196-0431",
    "DEASCHEDULE": "",
    "LABELERNAME": "Central Admixture Pharmacy Services, Inc.",
    "SUBSTANCENAME": "HEPARIN SODIUM; LYSINE ACETATE; SERINE; TYROSINE; N-ACETYLTYROSINE; THREONINE; CYSTEINE HYDROCHLORIDE; HISTIDINE; ARGININE; TAURINE; DEXTROSE MONOHYDRATE; LEUCINE; METHIONINE; GLUTAMIC ACID; PROLINE; ASPARTIC ACID; ISOLEUCINE; ALANINE; GLYCINE; PHENYLALANINE; TRYPTOPHAN; VALINE",
    "DOSAGEFORMNAME": "SOLUTION",
    "NDCPACKAGECODE": "72196-0431-1",
    "PRODUCTTYPENAME": "HUMAN COMPOUNDED DRUG",
    "PROPRIETARYNAME": "Trophamine 3.5%/Dextrose 10% and Heparin 125 units 250ml bag",
    "REPORTINGPERIOD": "2025-1",
    "NONPROPRIETARYNAME": "Trophamine 3.5%/Dextrose 10% and Heparin 125 units 250ml bag",
    "PACKAGEDESCRIPTION": "250 mL in 1 BAG (72196-0431-1) ",
    "ACTIVEINGREDIENTSINFO": "125 U/250 mL; 1.05 g/250 mL; .3325 g/250 mL; .0385 g/250 mL; .21 g/250 mL; .3675 g/250 mL; .021 g/250 mL; .42 g/250 mL; 1.05 g/250 mL; .021875 g/250 mL; 25 g/250 mL; 1.225 g/250 mL; .2975 g/250 mL; .4375 g/250 mL; .595 g/250 mL; .28 g/250 mL; .7175 g/250 mL; .4725 g/250 mL; .315 g/250 mL; .42 g/250 mL; .175 g/250 mL; .6825 g/250 mL",
    "MARKETINGCATEGORYNAME": "OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)",
    "PROPRIETARYNAMESUFFIX": ""
}

Normalization notes#

[]

Current status projection#

Dataset
compounder
Record Source
ndc_compounder_zip
Source Record Id
compounder:3134
Source Row Number
3134
Status Scope
package
Lookup Ndc
72196-0431-1
Lookup Ndc Digits
7219604311
Product Ndc
72196-0431
Product Ndc Digits
721960431
Package Ndc
72196-0431-1
Package Ndc Digits
7219604311
Package Ndc11
72196043101
Product Id
[empty]
Status Code
COMPOUNDER
Status Label
Outsourcing facility compounded drug report
Reporting Period Raw
2025-1
Reporting Period
2025-1
Source Table
fda_ndc_aux_compounder
Source File
compounders_ndc_directory.txt
Source Date
2026-09-18
Source Row Hash
792d1fafdfa2c05838babae064f75a7cf747977dc1d4103e7336491c867c6f4c
Import Run Id
20261119T172627Z
Loaded At
2026-11-19 17:42:45